We’re proud to once again be ranked in the top five of Americas Most Just companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help create a healthier world for all.
In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.
Lauren Huffmaster received a late-stage metastatic breast cancer (mBC) diagnosis in 2015 and soon discovered there wasn’t a lot information to help explain to her young children what she was going through.
Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we’ll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.
As a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals.
See, Vice President of Oncology Clinical Development at Gilead, took a moment to walk us through some of the new innovations in breast cancer and the work underway at Gilead Oncology, where the vision is to help bring more life to people with cancer.
As Gilead maps out its next decade, including plans for a new Research Center in Foster City, we talked with Flavius about Gilead’s history of innovation and plans for the future.
This year, she implemented a plan to remedy that – and with the support of a Gilead TRANScend grant, the Transinclusive Group opened a peer-run seven-bed housing program called CHOICES.
Dancing has always been a part of Shadae McDaniel's life. When she was part of an ensemble, she and her fellow dancers would rehearse their routines over and over, trying to ensure they were ready for the stage.
Since the beginning of the COVID-19 pandemic, Gilead’s first-in-class antiviral was made available to more than 11 million patients globally– over 65% of whom live in low-and lower-middle-income countries.
Before Rashad Burgess held the professional title of Vice President of Advancing Health and Equity at Gilead Sciences or the personal identification of husband and father
Alonzo Henderson is the Media, Communications and Technical Assistant for Kingmakers of Oakland, a nonprofit dedicated to improving the lives of Black youth in public school systems.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...